Here’s a roundup of companies announcing clearances and approvals from the Food & Drug Administration and foreign regulatory agencies. Check out MassDevice’s compilation of the latest regulatory news for additional clearances and approvals.
NFocus Neuromedical Inc. is developing a new treatment for brain aneurysms that could end up giving companies like Johnson & Johnson (NYSE:JNJ), Stryker (NYSE:SYK) and Covidien (NYSE:COV) a real headache.